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Compared to the general population, the suicide risk among Danish cancer patients diagnosed in 1971–1986 was increased by 50%
for men and 30% for women. We updated the earlier study to evaluate both long-term and recent trends in the suicide risk. Cancer
patients with a first cancer diagnosed between 1971 and 1999 in Denmark were followed-up for completed suicide through 1999.
Excluding nonmelanoma skin cancer, 564508 cancer patients were included and 1241 suicides observed. Both the standardised
mortality ratio (SMR) of suicide relative to the general population and the suicide rates were analysed with Poisson regression
methods. The overall SMR was increased to 1.7 (95% CI. 1.6–1.9) for men and 1.4 (95% CI: 1.3–1.5) for women. Following the
cancer diagnosis, the suicide risk was highest in the first 3 months for men and between months 3 and 12 for women. The risk was
higher for nonlocalised cancer and for cancers with perceived poor prognosis. Breast cancer patients had a higher risk than other
cancer patients with similar good prognosis. The suicide rates among cancer patients decreased with calendar time, but less so than
the rates in the general population. The suicide risk among cancer patients has not decreased as much as in the Danish population
and reasons for this should be explored. Breast cancer might be believed by patients to be more life threatening than it is. Assessment
and treatment of depression could improve the quality of life for cancer patients who suffer from unrecognised depressions and in
turn reduce the risk of suicide in cancer patients.
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Somatic disease is a well-documented risk factor for completed
suicide. Using register-based data, a 1.3–3 times increased suicide
risk has been found among cancer patients in many countries
(Louhivouri and Hakama 1979; Fox et al, 1982; Allebeck et al, 1989;
Levi et al, 1991; Storm et al, 1992; Harris and Barraclough, 1994;
Crocetti et al, 1998; Tanaka et al, 1999; Miccinesi et al, 2004).
Studies on suicides in cancer patients have suggested that suicide
risk is inversely correlated with time since diagnosis, increased
with advanced cancer stage, higher for men than women, and
varying with cancer site and age.
With 13 more years of incidence and follow-up, our study
almost doubles the earlier study (Storm et al, 1992), which covered
the risk of suicide and other violent deaths among 296331 Danish
cancer patients diagnosed in the period 1971–1986. Compared to
the general Danish population, the observed 568 suicides
represented increased suicide risks of 50% for men and 30% for
women; risk was higher with nonlocalised cancers, and it increased
by calendar time.
We conducted a detailed register and population-based cohort
study among Danish cancer patients diagnosed and reported to the
Danish Cancer Registry in the years 1971–1999.
MATERIALS AND METHODS
All cancer patients identified in the Danish Cancer Register (Storm
et al, 1997) with a first cancer, excluding nonmelanoma skin
cancer, in the period 1971–1999, were followed up in the Danish
Causes of Death Register (Juel and Helweg-Larsen, 1999). Follow-
up was from the cancer diagnosis to the first of the following
events: a second cancer, emigration, death, or end of study, 31
December 1999. We excluded patients with two simultaneously
diagnosed cancers (3846 patients, 0.7%) or with a first cancer
diagnosis reported on a death certificate alone or if the cancer was
diagnosed at an autopsy (26513 patients, 4.5%). Although primary
outcome was suicide, we also examined other violent causes of
death to evaluate a possible misclassification of suicides.
In addition to cancer site, gender, age and date of diagnosis, date
of death, and cause of death, we also recorded the stage of the
tumour at diagnosis as localised, regional spread, remote
metastasis, or unknown. Cancer sites were analysed both grouped
in broad ICD categories (Sundhedsstyrelsen, 2003), and according
to the prognosis mesured by the 5-year relative survival as being
high (466%), medium (33–66%), and low (o33%) as shown in
Table 1. (Storm and Engholm, 2002).
The person years at risk were grouped according to time since
diagnosis into less than 3 months, 3–12 months, 1–2 years, 3–4
years, and 5 or more years, and stratified by age and calendar time
in 5-year groups. The expected numbers of suicides were
calculated by multiplying the risk time with the Danish population
suicide rates in 5-year age and calendar time groups for each
gender. The standardised mortality ratio (SMR) of suicide is
defined as the observed divided by expected number of suicides,
and the suicide rates as the observed number divided by the
person years at risk.
The SMR and the rates were analysed using Poisson regression
methods, assuming that the number of suicides follow a Poisson
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sdistribution. In the analysis of SMR, the logarithm of the expected
number of suicides was used as the offset variable, while in the rate
–analysis, the logarithm of the person years at risk was used.
In the analyses, the following factors were considered in the
multiplicative models: age at cancer diagnosis, calendar time at
diagnosis, the cancer site, time since diagnosis, and stage at
diagnosis. For each factor, one of the categories was chosen as a
reference, and the estimated parameters for the other categories
interpreted as the relative risk compared to the reference, adjusted
for the other factors in the model. The reference category was
mostly chosen as the category with the highest number of suicides.
Different types of categorisation of cancer sites were tried out:
main ICD groups, individual cancer sites, and according to
prognosis. Prognosis was divided into three groups using 5-year
relative survival ratios for cancer patients in Denmark diagnosed
during 1991–1995 (Storm and Engholm, 2002) as showed in
Table 1. The 95% confidence intervals (95% CI) were reported, but
a significance level of 1% was used due to the large data set and the
relatively simple models. SAS version 8.02 was used for the
analyses (SAS Institute INC, Cary, NC, USA).
RESULTS
During the study period 1971–1999, a total of 564508 cancer
patients were included, contributing 861713 person years at risk
among men and 1370828 person years at risk among women.
Suicide
A total of 1241 suicides (740 men, 501 women) were observed. The
overall SMR of suicide was 1.7 (95% CI: 1.6–1.8) for men and 1.4
(95% CI: 1.3–1.5) for women.
Time since diagnosis The adjusted relative risk (RR) of commit-
ting suicide was highest during the first 3 months after the cancer
diagnosis for men and from 3 months to 1 year after the diagnosis
for women, both when studying the SMR and the rates (Tables 2
and 3).
Calendar period at diagnosis For the SMR, the RR was stable
from 1971 to 1990, whereafter the RR increased until the end of the
study period in 1999. The changes in SMR were significant for men
but not for women. For rates, the adjusted RR decreased
marginally during the study period (Tables 2 and 3).
Stage For both genders, the adjusted RR of suicide increased by
severity of clinical stage at the time of diagnosis, but not
significantly for women. (Tables 2 and 3).
Cancer site The adjusted RR of suicide according to cancer site
was significantly elevated for men in the following main groups:
Respiratory system, other specified sites, and Secondary and
unspecified sites. For women, the RR was significantly elevated for
Respiratory system, Breast, and Secondary and unspecified sites
(results not shown).
We found a surprisingly good fit of the models with cancer sites
according to prognosis divided into good, medium, and low
relative survival. The RR of suicide was highest among patients
with poor prognosis cancer, and also when we adjusted for the
other risk factors (Tables 2 and 3). Breast cancer had a deviating
pattern with a higher suicide risk than other cancer sites with good
prognosis (Table 3).
Age at diagnosis The adjusted RR increased with age for men and
was highest for women at ages 50–79 years in the rate models,
while no significant variation was found in the SMR models
(Tables 2 and 3).
Interactions We checked for interactions between risk factors,
but found no significant interactions at the 1% level.
Other violent deaths
In total, 3038 (1349 for men and 1689 for women) violent deaths
other than suicide were observed. The SMR of death by traffic
accident and by accidental poisoning was not significantly
elevated. The SMR of death due to murder or other violence,
and to other accidents than fall accidents was significantly
elevated, but since the numbers of cancer patients with these
outcomes were small (217 among men and 192 among women), no
further analyses were made (data not shown).
Death by fall Death by fall accidents constituted the majority of
other violent deaths, 878 among men and 1329 among women. The
overall SMR of death by fall accident was 1.2 (95% CI: 1.2–1.3) for
men and 1.2 (95% CI: 1.2–1.3) for women. The RR was highest
right after the cancer diagnosis, and more so among patients with
metastatic cancer. The risk increased during the study period; it
was highest at ages 50–64 years, and among patients with poor
prognosis cancer. All factors were significant in the adjusted
models among women and, except for period at diagnosis, also for
men.
DISCUSSION
The overall suicide risk of cancer patients relative to the
population risk in our study was marginally elevated compared
to the RR reported by Storm et al (1992).
Time since cancer diagnosis
The strongest risk factor for suicide was time since the cancer
diagnosis. The increased suicide risk following diagnosis shows the
need for psychosocial care and support. Many cancer patients are
going through a crisis trying to cope with the fact that they have a
life-threatening disease. Tanaka et al (1999) found the highest
suicide risk between the third and fifth month following diagnosis
and the suicides committed in this period were immediately after
discharge from hospital. Difficulties of psychological adjustment
without the support of the hospital environment might be one
possible explanation. We similarly discovered a peak in suicides
between 3 and 12 months after diagnosis for women, whereas the
highest suicide risk for men was within the first 3 months
following diagnosis. Time since cancer diagnoses was only
borderline significant among women after adjusting for the other
risk factors. The different suicide pattern seen for gender may be
Table 1 Cancer sites grouped according to prognosis by cancer site
measured by good (466%), medium (33–66%), and poor (o33%) 5-year
relative survival in Denmark for cancers diagnosed during 1991–1995
Prognosis 5-year
relative survival Cancer sites
Good (466%) Lip, breast, cervix, corpus, testis, melanoma skin, thyroid,
Hodgkin’s disease
Medium (33–66%) Salivary glands, mouth, colon, rectum, nasal cavity, larynx,
uterus, prostate, kidney, bladder, eye, brain and nervous
system, endocrine glands, bone, connective tissue, non-
Hodgkin’s lymphoma, leukaemia, mycosis fungoides
Poor (o33%) Tongue, pharynx, oesophagus, stomach, small intestine,
liver, gall bladder, pancreas, peritoneum, lung, pleura,
ovary, metastases, multiple myeloma
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sexplained by a higher success rate of suicide attempts among men
as they, in general, use more determined suicide methods than
women (Sundhedsstyrelsen, 1998).
The suicide risk remained elevated more than 5 years after
diagnosis, which could be explained by terminally ill patients who
commit suicide to avoid suffering in the last phases of their illness,
or by recurrent or metastatic disease developing. These states are
not recorded by the cancer registry and it is thus not possible to
study using register data.
Study period
The suicide rates in the general Danish population have changed
dramatically during our study period. The suicide rate peaked in
Denmark in 1981–1985 with a world age standardized rate per
100000 of 30 for men and 16 for women. It has been falling steadily
ever since – to 17 for men and 6 for women in 1996–1999 (Table 4).
The suicide rates for cancer patients also decreased, but not as
much as seen in the general population; hence, the SMR for suicide
increased for cancer patients during our study period. This trend
was also observed by Storm et al (1992) for the period up to 1986.
Although suicide might seem rational for the terminally ill
patient or for patients with poor prognosis, a suicide is rare in the
absence of a psychiatric disorder, even among cancer patients
(Hietanen and Lo ¨nnquist, 1991; Filiberti et al, 2001).
The prevalence of depression in the cancer population has been
estimated to be 10–30% depending on the diagnostic criteria used
(Chochinov et al, 1994; Breitbart et al, 2000; Ciaramella and Poli,
2001).
The increased suicide risk points to the importance of health
professionals recognising the symptoms of depression in cancer
patients and acting accordingly. Diagnosis of depression in cancer
patients can be challenging because sadness is part of a natural
emotional reaction of being diagnosed with cancer, and many
nonspecific somatic symptoms frequently associated with depres-
sion can result from the cancer itself. The increasing SMR for
suicide among cancer patients during our study period could
indicate that depression among Danish cancer patients is under-
diagnosed and undertreated as seen by Tiernan et al (2002).
The increasing SMR for suicide with calendar time in Danish
cancer patients is in contrast with a recently published Italian
study based on 102 cancer suicides. The SMR for suicide decreased
with calendar time from 1985 to 1999 in Central Italy, which is a
Table 2 Suicides among men with a first cancer, excluding nonmelanoma skin cancer, in the Danish Cancer Register 1971–1999
Models of SMR
Model of rates
Number
observed
(N¼740)
Number
expected
(N¼439.7)
Person-years
(%)
(N¼861713) Univariate RR (95% CI)
Multivariate RR
(95% CI) Multivariate RR (95% CI)
Intercept 1.2 (1.0–1.5) (7.4 (5.9–9.2))*10
 4
Time since diagnosis
Intercept/P-value 1.2 (1.0–1.4)/Po0.00001 Po0.00001 Po0.00001
o0.25 year 117 30.2 6.7 3.3 (2.6–4.1) 2.4 (1.9–3.1) 2.4 (1.9–3.1)
0.25–o1 year 140 63.1 14.1 1.9 (1.5–2.3) 1.5 (1.2–1.9) 1.5 (1.2–1.9)
1–o3 year 185 106.2 24.0 1.5 (1.2–1.8) 1.3 (1.1–1.6) 1.3 (1.1–1.6)
3–o5 year 95 69.0 15.6 1.2 (0.9–1.5) 1.1 (0.8–1.4) 1.1 (0.8–1.4)
5+ year 203 171.2 39.6 1 1 1
Stage of cancer
Intercept/P-value 1.4 (1.3–1.5)/Po0.00001 P¼0.002 P¼0.005
Localised 408 294.5 66.3 1 1 1
Regional 102 51.8 12.0 1.4 (1.1–1.8) 1.1 (0.9–1.3) 1.1 (0.8–1.3)
Metastasised 78 27.6 6.2 2.0 (1.6–2.6) 1.4 (1.1–1.8) 1.4 (1.1–1.8)
Unknown 152 65.9 15.5 1.7 (1.4–2.0) 1.4 (1.2–1.7) 1.4 (1.1–1.7)
Period of diagnosis
Intercept/P-value 1.7 (1.4–1.9)/Po0.00001 P¼0.004 P¼0.09
1971–1975 93 82.6 17.5 0.7 (0.5–0.9) 0.7 (0.5–0.9) 0.7 (0.5–0.9)
1976–1980 162 97.9 20.7 1 1 1
1981–1985 158 96.6 20.6 1.0 (0.8–1.2) 0.9 (0.8–1.2) 0.9 (0.8–1.2)
1986–1990 150 85.3 19.9 1.1 (0.9–1.3) 1.0 (0.8–1.2) 0.9 (0.7–1.1)
1991–1995 121 58.5 15.6 1.3 (1.0–1.6) 1.1 (0.9–1.4) 0.8 (0.7–1.1)
1996–1999 56 18.8 5.7 1.8 (1.3–2.4) 1.3 (0.9–1.8) 0.8 (0.6–1.1)
Age at diagnosis (years)
Intercept/P-value 1.7 (1.5–1.9)/P¼0.17 P¼0.07 P¼0.005
0–49 115 81.2 25.9 0.8 (0.7–1.0) 1.2 (0.9–1.5) 0.7 (0.6–0.9)
50–64 237 130.3 30.9 1.1 (0.9–1.3) 1.2 (1.0–1.4) 1.0 (0.8–1.2)
65–79 314 184.1 37.0 1 1 1
80+ 74 44.2 6.3 1.0 (0.8–1.3) 0.8 (0.7–1.1) 1.3 (1.0–1.6)
Prognosis of cancer site
Intercept/P-value 1.6 (1.5–1.7)/Po0.00001 Po0.00001 Po0 .00001
Good (+66%) 70 73.7 19.7 0.6 (0.5–0.8) 0.6 (0.5–0.8) 0.6 (0.5–0.8)
Medium (33–66%) 183 60.4 66.9 1 1 1
Poor (0–33%) 487 305.7 13.4 1.9 (1.6–2.3) 1.6 (1.3–1.9) 1.6 (1.3–1.9)
Multivariate models included the factors time since diagnosis, stage of cancer, period of diagnosis, age at diagnosis, and prognosis of cancer site measured by 5-year relative
survival. Models of standardised mortality ratio (SMR) and rates showing relative risk (RR) in both univariate and multivariate models.
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slow incidence suicide area. Miccinesi et al (2004) proposed that
better treatment options and better communication of diagnosis
were possible explanations of their finding. The SMR calculated in
the Miccinesi study was only adjusted for time since diagnosis, and
only analysed for men and women combined.
The first cancer counselling centre in Denmark, offering
information and psychological counselling to patients and
relatives, was founded in 1978 in Copenhagen. Today every county
in Denmark has a cancer counselling centre and the major
oncology departments have a psychologist who educates the staff
in dealing with psychosocial problems. Furthermore, a 5-day
course in communication is now mandatory in the postgraduate
training of doctors, so the psychosocial aspect of a cancer
diagnosis has become much more recognised during our study
period. All of this should ideally lead to a lower suicide risk than
before in cancer patients, approximating that of the general
Table 3 Suicides among women with a first cancer, excluding nonmelanoma skin cancer, in the Danish Cancer Register 1971–1999
Models of SMR
Model of rates
Number
observed
(N¼501)
Number
expected
(N¼361.4)
Person-years
(%)
(N¼1370828) Univariate RR (95% CI)
Multivariate RR
(95% CI)
Multivariate RR
(95% CI)
Intercept 1.0 (0.7–1.3) (2.8 (2.1–3.8)) *10
 4
Time since diagnosis
Intercept/P-value 1.1 (1.0–1.3)/P¼0.00003 P¼0.02 Po0.00001
o0.25 year 32 17.6 4.6 1.6 (1.1–2.4) 1.3 (0.9–1.9) 1.7 (1.1–2.5)
0.25–o1 year 86 41.2 10.9 1.9 (1.5–2.4) 1.6 (1.2–2.1) 2.0 (1.6–2.7)
1–o3 year 127 79.3 21.2 1.4 (1.2–1.8) 1.3 (1.0–1.6) 1.6 (1.3–2.0)
3–o5 year 71 57.2 15.5 1.1 (0.9–1.5) 1.0 (0.8–1.4) 1.2 (0.9–1.6)
5+ year 185 166.1 47.8 1 1 1
Stage of cancer
Intercept/P-value 1.3 (1.1–1.4)/Po0.00001 P¼0.26 P¼0.30
Localised 318 253.9 69.6 1 1 1
Regional 97 63.1 17.6 1.2 (1.0–1.5) 1.0 (0.8–1.3) 1.0 (0.8–1.3)
Metastasised 29 12.0 3.2 1.9 (1.3–2.8) 1.4 (0.9–2.1) 1.4 (0.9–2.1)
Unknown 57 32.4 9.6 1.4 (1.1–1.9) 1.3 (0.9–1.7) 1.2 (0.9–1.6)
Period of diagnosis
Intercept/P-value 1.3 (1.0–1.5)/P¼0.0009 P¼0.10 P¼0.08
1971–1975 94 83.7 19.8 0.9 (0.7–1.2) 0.9 (0.7–1.2) 1.0 (0.7–1.3)
1976–1980 112 89.3 21.7 1 1 1
1981–1985 118 80.7 21.0 1.2 (0.9–1.5) 1.1 (0.9–1.5) 1.1 (0.8–1.4)
1986–1990 82 62.0 18.9 1.1 (0.8–1.4) 1.0 (0.7–1.3) 0.8 (0.6–1.0)
1991–1995 73 36.7 14.1 1.6 (1.2–2.1) 1.4 (1.0–1.9) 0.8 (0.6–1.1)
1996–1999 22 9.0 4.6 2.0 (1.2–3.1) 1.5 (0.9–2.4) 0.6 (0.4–1.0)
Age at diagnosis
Intercept/P-value 1.5 (1.3–1.7)/P¼0.70 P¼0.80 P¼0.04
0–49 120 92.0 30.2 0.9 (0.7–1.1) 1.0 (0.8–1.3) 0.8 (0.6–1.0)
50–64 193 142.4 35.4 0.9 (0.7–1.1) 1.0 (0.8–1.2) 1.0 (0.8–1.2)
65–79 164 109.8 28.8 1 1 1
80+ 24 17.2 5.6 1.0 (0.6–1.4) 0.8 (0.5–1.3) 0.7 (0.4–1.1)
Prognosis of cancer site
Intercept/P-value 1.5 (1.3–1.7)/P¼0.0001 P¼0.002 P¼0 .0005
Good (+ 66%) 104 97.7 27.3 0.8 ( 0.6–1.1) 0.9 (0.7–1.2) 0.9 (0.7–1.2)
Medium (33–66%) 120 94.7 27.0 1 1 1
Poor (0–33%) 78 34.7 9.4 1.8 (1.3–2.4) 1.6 (1.2–2.1) 1.7 (1.2–2.2)
Breast cancer 199 134.2 36.4 1.2 (0.9–1.5) 1.2 (1.0–1.5) 1.3 (1.0–1.6)
Multivariate models included the factors time since diagnosis, stage of cancer, period of diagnosis, age at diagnosis and prognosis of cancer site measured by 5-year relative
survival. Models of standardised mortality ratio (SMR) and rates showing relative risk (RR) in both univariate and multivariate models.
Table 4 Number of suicides in Denmark per year and age-standardised (world) suicide rates (WSTP) per 100000 in 1971–1999
Men Women
Calendar year Observed number per year Rate (WSTP) Observed number per year Rate (WSTP)
1971–1975 766 26.2 460 14.8
1976–1980 817 27.4 498 15.5
1981–1985 931 30.2 542 16.3
1986–1990 868 26.7 493 14.0
1991–1996 711 21.1 364 9.4
1996–1999 575 16.8 233 6.1
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spopulation; however, this was not observed. One may speculate
whether the increased openness and the demand on patients to be
involved in the decision process about their therapy lead to
unwarranted outcomes such as suicides.
Stage, prognosis, and cancer site
The suicide risk increased with the severity of clinical stage at the
time of diagnosis as seen by others (Louhivouri and Hakama, 1979;
Storm et al, 1992; Tanaka et al, 1999), for news of metastatic cancer
must be a shock. Furthermore, widespread cancer may cause
profound pain and physical impairment, besides a poor prognosis.
Different sites have been associated with the highest suicide risks,
including gastrointestinal cancer (Louhivouri and Hakama, 1979),
respiratory and gastrointestinal cancers (Allebeck et al, 1989),
genital cancers (Tanaka et al, 1999), and stomach, rectum, kidney,
brain and nervous system cancers (Storm et al, 1992). The
differences probably reflect that the numbers associated with each
site are small even in large cohorts; therefore, the risk estimates are
unstable.
Cancers with a poor prognosis, here measured by low 5-year
relative survival ratio, yielded the highest risks of suicide.
Aggregating cancer diagnosis in three groups according to
prognosis and using this factor together with stage in the analyses
showed a good fit of the models. Female breast cancer patients had
a good prognosis, but a high suicide risk, even when adjusted for
stage. For women we improved the model fit by keeping breast
cancer as a separate category in the prognosis factor and found no
interaction with stage. The influence of surgery, especially
mastectomy, on psychosocial and psychosexual perception may
play a role in suicide by breast cancer patients. An American study
of breast cancer patients showed major depressive disorder among
9% and distress among 29% (Coyne et al, 2004) and suggested that
diagnosis and treatment of breast cancer have a big influence on
psychosocial functioning. Breast cancer patients may consider
their disease more life-threatening than it is.
We excluded nonmelanoma skin cancer because it is not
considered a life-threatening disease. Whether such patients do
have a similar suicide risk to the population risk will be evaluated
in another paper.
Age at diagnosis
Older age and depressed mood are important risk factors for suicide
in the population, with highest risk for men above 80 years of age
and for women aged 50–79 years (Akechi et al, 2000, Erlangsen,
2004), perhaps because suicide attempts are often more successful
for men. A similar pattern was found among cancer patients. Age
was significant in modelling of the rates as seen in Tables 2 and 3,
but insignificant in models where the risk in the cancer population
was compared to the population risk, that is, the SMR models.
Validity of suicide statistics
We investigated whether the high relative risk of dying from falls,
especially for women, could be hidden suicides. Our findings
support this idea. The high SMR for death from falls immediately
after cancer diagnosis and increasing with severity of clinical stage
follows the same pattern as the cancer patients’ SMR for death by
suicide. The relative risk of death from falls was highest at ages
0–49 and 50–64 years for both men and women. If the excess risk
of such deaths was ascribed to hidden suicides, this would
maximally increase the total number of suicides by 8% for men
and 14% for women. Other plausible explanations exist such as side
effects of cancer medications, delirious states, and general weakness.
The Danish suicide rates have always been high compared with
most other countries. In Denmark, suicide is not a criminal act.
Furthermore, as a secular society, suicide is not connected with
strong religious condemnation. All cases of unexpected and violent
deaths are examined by the police and a specialist in forensic
medicine (Atkinson et al, 1975; Hess, 1987; Kolmos and Bach,
1987). Kolmos and Bach (1987) searched the Danish registers for
possible misclassifications related to poisoning and drowning, and
concluded that the suicide statistics in Denmark are reliable and
come close to reflecting the true suicide rate. Misclassification of
suicide as accidental falls has only been suggested by Storm et al
(1992) and this study.
CONCLUSION
Our study included the 1241 suicides in a cohort of 564517 Danish
cancer patients diagnosed between 1971 and 1999, which makes it
the largest study to date on suicide and cancer. It is based on the
Danish Cancer Register (Storm et al, 1997), one of the most
complete nationwide cancer registers in the world, and the Danish
Register of Causes of Death (Juel and Helweg-Larsen, 1999). Our
study is a cohort study based on linkage of independent registers,
thus avoiding information bias and recall bias.
We have shown that a diagnosis of cancer is a risk factor of
suicide for both genders, and we identified certain groups among
cancer patients at very high risk of committing suicide: the suicide
risk was higher for men than for women. The suicide risk was
highest the year following diagnosis, but remained elevated even
after 5 years from diagnosis. Cancer patients diagnosed between 50
and 79 years of age committed the majority of suicides. A
diagnosis of cancer with poor prognosis and cancer with
metastases at the time of diagnosis gave a high relative risk of
suicide. The SMR of suicide increased with calendar time, although
the total number of suicides decreased. Our results are in
agreement with other studies on the link between cancer and
suicide and suicide and physical disease in general (Louhivouri
and Hakama, 1979; Fox et al, 1982; Allebeck et al, 1989; Levi et al,
1991; Storm et al, 1992; Harris and Barraclough, 1994; Stenager
et al, 1994; Crocetti et al, 1998; Stenager et al, 1998; Tanaka et al,
1999; Miccinesi et al, 2004). The marginal and adjusted analyses of
SMR of suicide and the analyses of the rates among cancer patients
show the stability of the results and facilitate comparison with
most other studies.
The total number of suicides among cancer patients was not
large, an average of 43 suicides per year with an excess number of
10–15, but it may be seen as an indicator of a high frequency of
shock and depression among cancer patients. We had no
possibility of controlling for other known risk factors of suicide,
such as unemployment, psychiatric disease, marital status, drug-
and/or alcohol abuse, and former suicide attempts (Mortensen
et al, 2000), as these factors are not routinely collected by the
registers used. Further research in this area should include a
linkage study between the Danish Cancer Register (Storm et al,
1997), the Danish Psychiatric Register (Munk-Jrgensen and
Mortensen, 1997), the Danish National Hospital Register (Ander-
sen et al, 1999), and the Register of Causes of Death (Juel and
Helweg-Larsen, 1999), in order to compare the prevalence of
psychiatric disorders in cancer patients committing suicide
relative to other cancer patients. Nested case control studies could
assess a possible connection between suicide more than a year
after cancer diagnosis and recurrent or metastasised cancer or
treatment failure, and the association between discharge from
hospital and increased suicide risk during the first year after a
cancer diagnosis should be studied.
In clinical practice, it is important to be aware that depression
and suicidal ideation in cancer patients are common and that
cancer patients are at an increased risk of suicide. Assessment and
treatment of depression could improve the quality of life for cancer
patients who suffer from unrecognised depressions and, in turn,
reduce the risk of suicide in cancer patients.
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